OrbiMed’s MiMedx Group MDXG Stock Holding History

OrbiMed’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-836,800	Closed	-$8.7M	–	144
2015 Q1	$8.7M	Hold	836,800	–	–	0.07%	107
2014 Q4	$9.65M	Buy	836,800 +41,400	+5%	+$409K	0.09%	95
2014 Q3	$5.67M	Hold	795,400	–	–	0.06%	111
2014 Q2	$5.64M	Hold	795,400	–	–	0.07%	107
2014 Q1	$4.88M	Buy	795,400 +95,400	+14%	+$701K	0.06%	119
2013 Q4	$6.12M	Buy	+700,000	New	+$4.29M	0.09%	93

Other funds holding MDXG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed's MDXG Position: Q2 2015 in Review

OrbiMed sold out of MiMedx Group (MDXG) in Q2 2015, closing a stake of 836,800 shares — an estimated $8.7M sold.

OrbiMed first reported a position in MDXG in Q4 2013 and held it in 6 quarters. The position peaked at $9.65M in Q4 2014. 169 funds tracked by Wall St. Rank hold MDXG as of Q2 2015.

OrbiMed reported no remaining MiMedx Group position as of Q2 2015 after selling out during the quarter.
OrbiMed sold 836,800 MiMedx Group shares in Q2 2015, an estimated $8.7M.
OrbiMed first reported a position in MiMedx Group in Q4 2013 and held it in 6 quarters.
OrbiMed's MiMedx Group position peaked at $9.65M in Q4 2014.
169 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2015.

Based on OrbiMed's 13F filing for Q2 2015, filed 14 Aug 2015.